before, clinical trials on GLP-one drugs have shown their Gains like a secondary prevention Instrument for cardiovascular disease (CVD), indicating they could reduce the chance of the heart attack or stroke in sufferers https://europeantimes.news/2024/08/belgium-battle-drugs-alcohol-hope/